Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs

Angewandte Chemie
Paul T BremerKim D Janda

Abstract

Fentanyl is an addictive prescription opioid that is over 80 times more potent than morphine. The synthetic nature of fentanyl has enabled the creation of dangerous "designer drug" analogues that escape toxicology screening, yet display comparable potency to the parent drug. Alarmingly, a large number of fatalities have been linked to overdose of fentanyl derivatives. Herein, we report an effective immunotherapy for reducing the psychoactive effects of fentanyl class drugs. A single conjugate vaccine was created that elicited high levels of antibodies with cross-reactivity for a wide panel of fentanyl analogues. Moreover, vaccinated mice gained significant protection from lethal fentanyl doses. Lastly, a surface plasmon resonance (SPR)-based technique was established enabling drug-specificity profiling of antibodies derived directly from serum. Our newly developed fentanyl vaccine and analytical methods may assist in the battle against synthetic opioid abuse.

References

Feb 1, 1991·Annals of Emergency Medicine·M MartinF Harchelroad
May 1, 1990·Journal of Analytical Toxicology·W RuangyuttikarnD E Moody
Jan 1, 1994·Methods in Enzymology·H Kunz, K von dem Bruch
Mar 9, 2000·Addiction·J M White, R J Irvine
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·M R CarreraK D Janda
Apr 1, 1962·British Journal of Anaesthesia·P A JANSSEN
Jul 26, 2005·Biological Psychiatry·Bridget A MartellThomas R Kosten
Mar 19, 2008·Analytical and Bioanalytical Chemistry·Goran Klenkar, Bo Liedberg
Apr 9, 2011·Journal of the American Chemical Society·Amira Y MorenoKim D Janda
Jun 23, 2011·Journal of Medicinal Chemistry·G Neil StoweKim D Janda
Sep 20, 2011·Bioorganic & Medicinal Chemistry·Ruben VardanyanVictor J Hruby
Nov 19, 2011·Annals of the New York Academy of Sciences·F Ivy CarrollP Anantha Reddy
Dec 17, 2011·Nature Reviews. Immunology·Kim D Janda, Jennifer B Treweek
May 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joel E SchlosburgGeorge F Koob
Aug 6, 2013·Life Sciences·Christopher L GermanGlen R Hanson
Feb 13, 2014·Molecular Pharmaceutics·Paul T BremerKim D Janda
Feb 14, 2014·Bioconjugate Chemistry·Karen C Collins, Kim D Janda
Dec 11, 2014·Journal of Medicinal Chemistry·Jonathan W LocknerKim D Janda
May 16, 2015·The International Journal on Drug Policy·Jane MounteneyPaul Griffiths

❮ Previous
Next ❯

Citations

Jul 22, 2016·Human Vaccines & Immunotherapeutics·Marco Pravetoni
Jun 1, 2017·The New England Journal of Medicine·Nora D Volkow, Francis S Collins
Jun 3, 2017·Journal of the American Chemical Society·Paul T BremerKim D Janda
Jun 7, 2017·Chembiochem : a European Journal of Chemical Biology·Shweta GanapatiLyle Isaacs
Jan 20, 2018·Journal of Bioethical Inquiry·Anna CarforaRenata Borriello
Nov 9, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carly Baehr, Marco Pravetoni
May 6, 2019·Journal of Molecular Modeling·Piotr F J LipińskiJoanna Sadlej
Nov 10, 2018·The Journal of Pharmacology and Experimental Therapeutics·Michael D RaleighMarco Pravetoni
Jun 22, 2017·Pharmacological Reviews·Paul T Bremer, Kim D Janda
Sep 1, 2019·International Journal of Molecular Sciences·Ye ZouHo-Leung Ng
Jun 6, 2019·Beilstein Journal of Organic Chemistry·Yoshihiro NatoriKim D Janda
Jan 7, 2020·Chemical Communications : Chem Comm·Weikun WangJovica D Badjić
Jan 17, 2019·Journal of Food and Drug Analysis·Hichem MoulahoumHakan Coskunol
May 13, 2020·Chemical Communications : Chem Comm·Jiaxing WangKim D Janda
Jun 5, 2019·BMJ Case Reports·Jorge A RoaJaime Guevara-Aguirre
Nov 10, 2017·Therapeutic Drug Monitoring·Simona PichiniFrancesco Paolo Busardò
May 3, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E Andrew TownsendMatthew L Banks
Oct 3, 2017·Annual Review of Pharmacology and Toxicology·Phil Skolnick
May 28, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brendan J Tunstall, Leandro F Vendruscolo
Aug 30, 2020·Journal of Analytical Toxicology·Pietro BrunettiAlfredo Fabrizio Lo Faro
Nov 19, 2020·Chemistry : a European Journal·Steven MurkliLyle Isaacs
Dec 4, 2020·Drug and Alcohol Dependence·E Andrew TownsendMatthew L Banks
Oct 27, 2020·Frontiers in Immunology·Morgan BrisseHinh Ly
Jan 11, 2018·Bioorganic & Medicinal Chemistry Letters·Atsushi KimishimaKim D Janda
Jun 30, 2021·International Immunopharmacology·Susana Barbosa-MéndezAlberto Salazar-Juárez
Aug 29, 2020·Journal of Agricultural and Food Chemistry·Kai WenZhanhui Wang
Mar 22, 2018·ACS Chemical Neuroscience·Candy S HwangKim D Janda
Aug 25, 2018·ACS Infectious Diseases·Ryan J ShireyKim D Janda
Oct 11, 2017·Biochemistry·Candy S Hwang, Kim D Janda
Nov 21, 2020·Journal of Medicinal Chemistry·Christine RobinsonMarco Pravetoni
Jun 13, 2019·Journal of the American Chemical Society·Lauren C SmithKim D Janda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advancing Clinical Care : Official Journal of NOAADN
D Dubiel
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
N Retterstol
© 2022 Meta ULC. All rights reserved